Development of K88-K99-987P-F41 tetravalent subunit vaccine against piglet colibacillosis IV.vaccine production and immunization efficacy experiment

LU Cheng-ping
DOI: https://doi.org/10.16303/j.cnki.1005-4545.2007.06.012
2007-01-01
Abstract:K88-ETEC,K99-ETEC,987P-ETEC and F41-ETEC strains were inoculated on appropriate medium repectively and bacteria fluids were collected.The tetravalent subunit vaccine containing purified K88,K99,987P and F41 adhesin antigens which were extracted by thermoextract method from four different ETEC and employing white oil as adjuvant was prepared.The vaccine was inoculated to mice and pregnant sows,at the same time antibodies produced from pregnant sows were detected after the product inspection.Challenging with the homogeneous strains at the determinate dose on days 15 after the vaccines being inoculated secondarily.The results were as follows:after the second immunization for mice,there was not significant difference in immune protection rate between the one-time-immunization and two-time-immunization.To piglets,in comparison with control group,the diarrhoea index remarkably reduced in both the one-time and two-time-immunization.Antibody titers began to rise 1 week post vaccination(23rd preparturition) and reached summit 2 week post vaccination(16th preparturition).After secondary vaccination antibody titers were rised rapidly,reached peak 4 week post vaccination(2 d preparturition),2 d postparturition declined to the almost same level to post-first-immunization.The morbility of piglets which were propagated from the sows immunized twice was obviously lower.These results indicuted that the tetravalent vaccine possessed an excellent immunogenicity and could provide an protection against piglet colibacillosis.
What problem does this paper attempt to address?